Logo image of CZR

CAESARS ENTERTAINMENT INC (CZR) Stock Fundamental Analysis

NASDAQ:CZR - Nasdaq - US12769G1004 - Common Stock - Currency: USD

29.41  -0.16 (-0.54%)

Premarket: 29.15 -0.26 (-0.88%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CZR. CZR was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of CZR have multiple concerns. CZR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CZR had negative earnings in the past year.
CZR had a positive operating cash flow in the past year.
In the past 5 years CZR reported 4 times negative net income.
Of the past 5 years CZR 4 years had a positive operating cash flow.
CZR Yearly Net Income VS EBIT VS OCF VS FCFCZR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

CZR's Return On Assets of -0.73% is on the low side compared to the rest of the industry. CZR is outperformed by 67.41% of its industry peers.
CZR's Return On Equity of -5.80% is in line compared to the rest of the industry. CZR outperforms 46.67% of its industry peers.
The Return On Invested Capital of CZR (5.94%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CZR is significantly below the industry average of 14.12%.
The 3 year average ROIC (5.76%) for CZR is below the current ROIC(5.94%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.73%
ROE -5.8%
ROIC 5.94%
ROA(3y)-0.39%
ROA(5y)-1.74%
ROE(3y)-4.54%
ROE(5y)-14.28%
ROIC(3y)5.76%
ROIC(5y)4.32%
CZR Yearly ROA, ROE, ROICCZR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

CZR has a better Operating Margin (20.13%) than 78.52% of its industry peers.
In the last couple of years the Operating Margin of CZR has grown nicely.
CZR has a Gross Margin (48.96%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CZR has remained more or less at the same level.
Industry RankSector Rank
OM 20.13%
PM (TTM) N/A
GM 48.96%
OM growth 3Y4.31%
OM growth 5Y2.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y-0.56%
CZR Yearly Profit, Operating, Gross MarginsCZR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

1

2. Health

2.1 Basic Checks

CZR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CZR has less shares outstanding than it did 1 year ago.
CZR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CZR has a worse debt to assets ratio.
CZR Yearly Shares OutstandingCZR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CZR Yearly Total Debt VS Total AssetsCZR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 0.57, we must say that CZR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CZR (0.57) is worse than 75.56% of its industry peers.
A Debt/Equity ratio of 6.16 is on the high side and indicates that CZR has dependencies on debt financing.
The Debt to Equity ratio of CZR (6.16) is worse than 62.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.16
Debt/FCF N/A
Altman-Z 0.57
ROIC/WACC1.02
WACC5.82%
CZR Yearly LT Debt VS Equity VS FCFCZR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 0.84 indicates that CZR may have some problems paying its short term obligations.
CZR's Current ratio of 0.84 is in line compared to the rest of the industry. CZR outperforms 46.67% of its industry peers.
A Quick Ratio of 0.82 indicates that CZR may have some problems paying its short term obligations.
The Quick ratio of CZR (0.82) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.82
CZR Yearly Current Assets VS Current LiabilitesCZR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

4

3. Growth

3.1 Past

CZR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.93%, which is quite impressive.
CZR shows a decrease in Revenue. In the last year, the revenue decreased by -1.25%.
The Revenue has been growing by 34.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)32.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.03%
Revenue 1Y (TTM)-1.25%
Revenue growth 3Y5.52%
Revenue growth 5Y34.78%
Sales Q2Q%1.9%

3.2 Future

CZR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 56.53% yearly.
CZR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.79% yearly.
EPS Next Y181.48%
EPS Next 2Y99.64%
EPS Next 3Y65.26%
EPS Next 5Y56.53%
Revenue Next Year2.18%
Revenue Next 2Y2.36%
Revenue Next 3Y2.37%
Revenue Next 5Y3.79%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CZR Yearly Revenue VS EstimatesCZR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B
CZR Yearly EPS VS EstimatesCZR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 -5 -10

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CZR. In the last year negative earnings were reported.
CZR is valuated rather expensively with a Price/Forward Earnings ratio of 20.01.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CZR is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CZR to the average of the S&P500 Index (22.43), we can say CZR is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 20.01
CZR Price Earnings VS Forward Price EarningsCZR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

CZR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CZR is cheaper than 74.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.36
CZR Per share dataCZR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CZR's earnings are expected to grow with 65.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y99.64%
EPS Next 3Y65.26%

More info and screens

0

5. Dividend

5.1 Amount

CZR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAESARS ENTERTAINMENT INC

NASDAQ:CZR (5/20/2025, 8:00:01 PM)

Premarket: 29.15 -0.26 (-0.88%)

29.41

-0.16 (-0.54%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-28 2025-07-28/amc
Inst Owners103.97%
Inst Owner Change5.49%
Ins Owners0.79%
Ins Owner Change3.19%
Market Cap6.12B
Analysts79
Price Target42.84 (45.66%)
Short Float %11.1%
Short Ratio3.59
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-23.27%
Min EPS beat(2)-183.48%
Max EPS beat(2)136.94%
EPS beat(4)1
Avg EPS beat(4)-73.75%
Min EPS beat(4)-183.48%
Max EPS beat(4)136.94%
EPS beat(8)2
Avg EPS beat(8)-299.54%
EPS beat(12)3
Avg EPS beat(12)-1076.58%
EPS beat(16)4
Avg EPS beat(16)-834.87%
Revenue beat(2)0
Avg Revenue beat(2)-1.22%
Min Revenue beat(2)-1.58%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.92%
Min Revenue beat(4)-2.68%
Max Revenue beat(4)-0.85%
Revenue beat(8)1
Avg Revenue beat(8)-1.66%
Revenue beat(12)4
Avg Revenue beat(12)-0.8%
Revenue beat(16)6
Avg Revenue beat(16)-0.46%
PT rev (1m)-11.76%
PT rev (3m)-14.52%
EPS NQ rev (1m)-24.01%
EPS NQ rev (3m)-18.85%
EPS NY rev (1m)-34.26%
EPS NY rev (3m)-48.48%
Revenue NQ rev (1m)-1.36%
Revenue NQ rev (3m)-1.3%
Revenue NY rev (1m)-1%
Revenue NY rev (3m)-1.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.01
P/S 0.54
P/FCF N/A
P/OCF 5.04
P/B 1.51
P/tB N/A
EV/EBITDA 8.36
EPS(TTM)-0.55
EYN/A
EPS(NY)1.47
Fwd EY5%
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)5.83
OCFY19.83%
SpS54.32
BVpS19.49
TBVpS-51.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.73%
ROE -5.8%
ROCE 7.51%
ROIC 5.94%
ROICexc 6.12%
ROICexgc 12.24%
OM 20.13%
PM (TTM) N/A
GM 48.96%
FCFM N/A
ROA(3y)-0.39%
ROA(5y)-1.74%
ROE(3y)-4.54%
ROE(5y)-14.28%
ROIC(3y)5.76%
ROIC(5y)4.32%
ROICexc(3y)5.94%
ROICexc(5y)4.47%
ROICexgc(3y)12.3%
ROICexgc(5y)9.19%
ROCE(3y)7.29%
ROCE(5y)5.47%
ROICexcg growth 3Y12.39%
ROICexcg growth 5Y-1.47%
ROICexc growth 3Y12.76%
ROICexc growth 5Y-4.07%
OM growth 3Y4.31%
OM growth 5Y2.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y-0.56%
F-Score4
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 6.16
Debt/FCF N/A
Debt/EBITDA 6.89
Cap/Depr 93.8%
Cap/Sales 11.24%
Interest Coverage 3.76
Cash Conversion 33.43%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.82
Altman-Z 0.57
F-Score4
WACC5.82%
ROIC/WACC1.02
Cap/Depr(3y)93.85%
Cap/Depr(5y)77.92%
Cap/Sales(3y)10.59%
Cap/Sales(5y)9.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.03%
EPS Next Y181.48%
EPS Next 2Y99.64%
EPS Next 3Y65.26%
EPS Next 5Y56.53%
Revenue 1Y (TTM)-1.25%
Revenue growth 3Y5.52%
Revenue growth 5Y34.78%
Sales Q2Q%1.9%
Revenue Next Year2.18%
Revenue Next 2Y2.36%
Revenue Next 3Y2.37%
Revenue Next 5Y3.79%
EBIT growth 1Y-6.27%
EBIT growth 3Y10.07%
EBIT growth 5Y38.4%
EBIT Next Year76.62%
EBIT Next 3Y23.32%
EBIT Next 5Y16.79%
FCF growth 1Y-114.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.85%
OCF growth 3Y-3.11%
OCF growth 5Y28.03%